Resistance Rates of Antituberculosis Drugs in Pulmonary Tuberculosis Patients Producing Mycobacterium Tuberculosis
dc.authorid | ÖZDEMİR, LEVENT/0000-0003-4578-9247 | |
dc.authorwosid | ÖZDEMİR, LEVENT/HJP-5498-2023 | |
dc.contributor.author | Perincek, Gokhan | |
dc.contributor.author | Tabakoglu, Erhan | |
dc.contributor.author | Otkun, Metin | |
dc.contributor.author | Ozdemir, Levent | |
dc.contributor.author | Ozdemir, Burcu | |
dc.date.accessioned | 2024-06-12T11:08:55Z | |
dc.date.available | 2024-06-12T11:08:55Z | |
dc.date.issued | 2011 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objective: Determination of antituberculosis drug resistance rate in pulmonary tuberculosis patients producing Mycobacterium tuberculosis. Material and Method: 134 pulmonary tuberculosis patients producing Mycobacterium tuberculosis in cultures in the Trakya University Medical Faculty Hospital between the years 2005-2007 were enrolled in the study. Four major antituberculosis drugs (H, R, streptomycin (SM), ethambutol (EMB)) resistance and multidrug resistance rates were investigated. using the BACTEC 460 TB system. Results: 134 pulmonary tuberculosis patients producing Mycobacterium tuberculosis were detected and 31 female patients were found and 103 male patients. Acid resistant bacilli were found in 58.2% of the patients with EZN. Antituberculosis resistance rates were established as H 10.4%, R 3%, EMB 0.7%, SM 0.7%. Conclusion: It was determined that a follow up of drug resistance patterns in patients with pulmonary tuberculosis will be useful in determining treatment protocols and preventing drug resistance. | en_US |
dc.identifier.doi | 10.5152/ttd.2011.25 | |
dc.identifier.endpage | 113 | en_US |
dc.identifier.issn | 1302-7808 | |
dc.identifier.issn | 1308-5387 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.scopus | 2-s2.0-80052065902 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 111 | en_US |
dc.identifier.uri | https://doi.org/10.5152/ttd.2011.25 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22604 | |
dc.identifier.volume | 12 | en_US |
dc.identifier.wos | WOS:000421721200006 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | tr | en_US |
dc.publisher | Aves | en_US |
dc.relation.ispartof | Turkish Thoracic Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Mycobacterium Tuberculosis | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Resistance | en_US |
dc.title | Resistance Rates of Antituberculosis Drugs in Pulmonary Tuberculosis Patients Producing Mycobacterium Tuberculosis | en_US |
dc.type | Article | en_US |